Pegylated recombinant human granulocyte colony-stimulating factor enhances radiotherapy completion and safety in concurrent chemoradiotherapy for cervical cancer: a retrospective analysis
{{output}}
Objective: To evaluate the impact of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) on radiotherapy completion rates and safety in cervical cancer patients undergoing concurrent chemoradiotherapy.... ...
